Ablation Devices Market is predicted to reach USD 18.6 Billion at a CAGR of 9.50% during the forecast 2032

Market Research Future (MRFR) has published on the “Ablation Devices Market”

MRFR recognizes the following companies as the key players in the global Ablation Devices market— Boston Scientific Corporation, Smith & Nephew PLC, St. Jude Medical, Inc., Medtronic PLC, Johnson and Johnson, BTG plc, AtriCure, Inc., Olympus Corporation, Conmed Corporation, AngioDynamics, Inc., Accuray Incorporated, C.R. Bard, Inc., Varian Medical Systems, Inc., Elekta AB, Misonix, Inc., Hologic, Inc., Stryker Corporation, EDAP TMS S.A., Japan Lifeline Co., Ltd., Halyard Health, Inc., Merit Medical Systems, Inc., Integra Lifesciences Holdings Corporation, Abbott Laboratories, and Terumo Corporation

Ablation Devices Market Highlights

The global ablation devices market is accounted to register a CAGR of 9.50% during the forecast period and is estimated to reach USD 18.6 Billion by 2032.

The industry that manufactures and distributes medical equipment intended to remove or destroy aberrant tissues during various medical operations is referred to as the "ablation devices market." The rising incidence of chronic diseases, technical improvements, and the expanding use of minimally invasive procedures are the main drivers of this industry. It offers a variety of cutting-edge tools, including cryoablation, laser ablation, and radiofrequency ablation, to give patients effective treatment alternatives.

Segment Analysis

The global ablation devices market has been segmented based technology, application, function and procedure.

On the basis of technology, the market is segmented into thermal ablation and non-thermal ablation. Thermal ablation segment dominated the global market in 2022.The portion will stay put for the entire anticipated time period.

Based on application, the global ablation devices market has been segmented into cancer, cardiovascular, ophthalmology, gynecology, urology, orthopedics, and others. Cancer segment dominated the global market in 2022.The high rate can be attributed to an increase in thyroid cancer cases globally.

Based on function, the global ablation devices market has been segmented into automated/robotic and conventional. Automated/robotic segment dominated the global Ablation Devices market in 2022. One of the most often used ablation methods for small tumors is radiofrequency ablation. The radio waves are quite energetic.

Based on procedure, the market is segmented into aesthetics-skin rejuvenation and tightening, aesthetics-body sculpting, fat reduction, and the reduction in the appearance of cellulite, benign prostatic hyperplasia, transurethral needle ablation, laser and other energy-based therapies/holmium laser ablation/enucleation of the prostate, stress urinary incontinence, menorrhagia/endometrial ablation, uterine fibroids, spinal decompression and denervation, varicose veins, atrial fibrillation, tumor ablation, and others. Aesthetics-skin rejuvenation and tightening segment dominated the global Ablation Devices market in 2022. The increased desire for cosmetic operations has something to do with this.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Ablation Devices Market Research Report

Regional Analysis

The global Ablation Devices market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Ablation Devices market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Ablation Devices market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Ablation Devices market comprises of Middle East, Africa, and Latin America.

The North America Ablation Devices Market dominated this market in 2022 (45.80%). The prevalence of thyroid cancer is rising, there are important participants in the market, and consumers have high purchasing power, all of which are significant drivers in the growth of the regional market. Further, the U.S. Ablation Devices market held the largest market share, and the Canada Ablation Devices market was the fastest growing market in the North America region.

Moreover, Europe Ablation Devices market accounted for the healthy market share in 2022. This is brought on by the availability of promising ablation technologies, rising demand for less invasive medical procedures, and rising disposable incomes.

Additionally, the Asia Pacific Ablation Devices market is expected to register significant growth from 2023 to 2032. The region's expanding patient base and growing demand for improved care are likely contributing factors to the rapid rise. Additionally, with government assistance, healthcare use is expanding throughout Asia and the Pacific.

Furthermore, the rest of the world's Ablation Devices market is divided into the Middle East, Africa, and Latin America. The demand for medical equipment used to remove or destroy aberrant tissues is met by the Latin America Ablation Devices Market. The market offers cutting-edge ablation equipment, such as radiofrequency ablation, laser ablation, and cryoablation, to give effective treatment choices in Latin American nations due to the rising prevalence of chronic diseases and the adoption of less invasive techniques.

Key Findings of the Study

• The global ablation devices market is expected to reach USD 18.6 Billion by 2032, at a CAGR of 9.50% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to the region's expanding patient base and growing demand for improved care are likely contributing factors to the rapid rise.


• Based on function, the automated/robot segment was attributed to holding the largest market in 2022.


• Boston Scientific Corporation, Smith & Nephew PLC, St. Jude Medical, Inc., Medtronic PLC, Johnson and Johnson, BTG plc, AtriCure, Inc., Olympus Corporation, Conmed Corporation, AngioDynamics, Inc., Accuray Incorporated, C.R. Bard, Inc., Varian Medical Systems, Inc., Elekta AB, Misonix, Inc., Hologic, Inc., Stryker Corporation, EDAP TMS S.A., Japan Lifeline Co., Ltd., Halyard Health, Inc., Merit Medical Systems, Inc., Integra Lifesciences Holdings Corporation, Abbott Laboratories, and Terumo Corporation